Evidence map›Paper›PMID 40136343›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Putting Patients First: Pragmatic Trials in Gynecologic Oncology.

Laura Hopkins, Mark Clemons, Karen Bemister, Chris Booth, Shannon Kadar, Paul Karanicolas, Julie Mulligan, Marie-France Savard, Ian Tannock, Alicia Tone and 1 more

Abstract readConference Proceedings
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laura HopkinsDepartment of Oncology, University of Saskatchewan, Saskatoon, SK S7V 4H4, Canada.
Mark ClemonsDepartment of Oncology, University of Ottawa, Ottawa, ON K1H 8L6, Canada.ORCID 0000-0001-9392-8219
Karen BemisterPatient Partners in Research, Ovarian Cancer Canada, Toronto, ON M2P 2A9, Canada.
Chris BoothDepartment of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada.
Shannon KadarPatient Partners in Research, Ovarian Cancer Canada, Toronto, ON M2P 2A9, Canada.
Paul KaranicolasDepartment of Surgery, University of Toronto, Toronto, ON M5S 3H2, Canada.
Julie MulliganPatient Partners in Research, Ovarian Cancer Canada, Toronto, ON M2P 2A9, Canada.
Marie-France SavardDepartment of Oncology, University of Ottawa, Ottawa, ON K1H 8L6, Canada.ORCID 0000-0002-7651-0870
Ian TannockDivision of Medical Oncology, University of Toronto, Toronto, ON M5S 3H2, Canada.
Alicia ToneOvarian Cancer Canada, Toronto, ON M2P 2A9, Canada.ORCID 0000-0001-9715-4273
Helen MacKayDivision of Medical Oncology and Hematology, University of Toronto, Toronto, ON M4N 3M5, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In November 2024, the Society of Gynecologic Oncology of Canada hosted a 2-day, interdisciplinary Pragmatic Clinical Trials (PCTs) Workshop with the goal of launching an initiative to develop and promote PCTs within the Canadian gynecologic oncology research environment. The programme brought together multiple stakeholders, including patients with ovarian cancer, patient advocates, experts in PCTs, gynecologic oncologists, medical oncologists and clinical fellows. Foundational elements of pragmatism were emphasized in the context of the primary goal of PCTs, showing the real-world effectiveness of interventions in broad patient groups. Examples of how PCT outcomes can inform and influence clinical decision making and health policy were presented in the context of those outcomes that matter most to patients with cancer. The patients and patient advocates had the essential role of helping clinical investigators co-design PCT protocols to answer common, important, and practical questions that focus on outcomes that matter to patients. These endpoints included overall survival, quality of life and promotion of informed patient decision making. Tangible workshop outcomes included the development of several new proposals for PCTs inspirited and directed by the patient voice. Further educational initiatives to engage clinical gynecologic oncology investigators at all stages in their career are being planned.

Indexed as

Genital Neoplasms, FemaleMedical OncologyPragmatic Clinical Trials as TopicCanadaFemaleHumansgynecologic oncologypatient engagementpragmatic clinical trialsREaCT

Identifiers

PMID40136343
PMCPMC11941110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.